Esta página se tradujo automáticamente y no se garantiza la precisión de la traducción. por favor refiérase a versión inglesa para un texto fuente.

A Multiphase Analysis of Next-generation Trail Footwear (NEXTGENTRAIL)

28 de septiembre de 2026 actualizado por: Fernando González-Mohíno Mayoralas

A Multiphase Analysis of Next-generation Trail Footwear: Optimising Advanced Footwear Technology From Laboratory Outcomes to Field-based Running Performance

This study will investigate how different advanced-foam trail-running footwear configurations affect running economy, performance, comfort, and fatigue in competitive trail runners. The project aims to determine whether footwear characteristics, particularly foam properties and stack height, influence physiological and biomechanical responses during both controlled laboratory running and real-world trail running.

Approximately 30 competitive trail runners with experience in technical trail running and no musculoskeletal injury during the previous six months will participate. The study will use a two-phase experimental design.

In Phase 1, participants will complete running economy assessments in three footwear conditions in randomized order. The footwear conditions will include a high-stack advanced-foam prototype, a medium-stack advanced-foam prototype, and a conventional-foam shoe. Laboratory testing will be performed during uphill and downhill treadmill running. Participants will also complete field-based running economy trials on real trail terrain at a controlled speed, followed by a short time trial to establish a representative running pace.

In Phase 2, participants will complete prolonged trail-running sessions in the two advanced-foam footwear configurations on a 15-km trail course. Running economy and fatigue-related responses will be assessed repeatedly during the prolonged exercise sessions to evaluate changes in physiological and biomechanical efficiency over time.

The primary physiological outcome will be running economy, assessed through oxygen consumption and energy cost. Additional outcomes will include heart rate, step frequency, step length, ground contact time, perceived exertion, comfort, perceived performance, and pacing-related measures.

The study will compare laboratory and field responses to determine whether differences in running economy observed under controlled conditions are maintained during real trail running and whether footwear configuration influences the deterioration of running economy and fatigue during prolonged exercise.

Descripción general del estudio

Estado

Aún no reclutando

Intervención / Tratamiento

Descripción detallada

Trail running involves substantial variations in terrain, gradient, and surface characteristics, creating physiological and biomechanical demands that differ from road running. Footwear may influence these responses through characteristics such as midsole foam properties, cushioning, and stack height. However, evidence regarding advanced footwear technology in trail running remains limited, particularly regarding whether laboratory findings translate to real-world trail conditions and whether footwear characteristics influence the maintenance of running performance during prolonged exercise.

The objective of this study is to investigate the effects of different advanced-foam trail-running footwear configurations on running economy, performance, comfort, biomechanical responses, and fatigue under laboratory and field-based trail-running conditions. The study will also examine whether footwear configuration influences durability, defined in this project as the maintenance of running economy and physiological efficiency during prolonged exercise.

The study will recruit approximately 30 competitive trail runners with experience in technical trail running who have been free from musculoskeletal injury for at least six months. Written informed consent will be obtained from all participants.

The study will use a two-phase experimental design.

In Phase 1, participants will be evaluated under three footwear conditions in randomized order:

  1. High-stack advanced-foam shoe prototype: approximately 38.5 mm stack height, 6-mm drop, and 220 g.
  2. Medium-stack advanced-foam shoe prototype: approximately 28.5 mm stack height, 6-mm drop, and 180 g.
  3. Conventional-foam footwear: approximately 31.5 mm stack height, 6-mm drop, and 300 g.

If necessary, shoe mass will be standardized by adding weight to the lighter footwear configurations to help isolate the effects of foam characteristics.

Laboratory running economy will be assessed using 5-minute running trials under uphill and downhill conditions. Uphill running will be performed at 8 km/h with a 6% positive slope, and downhill running at 16 km/h with a 6% negative slope. Oxygen uptake and carbon dioxide output will be measured breath-by-breath using a metabolic gas analysis system. Biomechanical variables will also be recorded, including step frequency and ground contact time.

Following the laboratory assessment, participants will complete field-based running economy trials on a real trail surface. Each footwear condition will be tested in randomized order during 5-minute running trials at a controlled speed of 12 km/h. Speed will be controlled using acoustic signals. Oxygen consumption and carbon dioxide production will be measured using a portable metabolic system, while spatiotemporal gait variables will be recorded using an inertial measurement device. Participants will subsequently complete a short time trial to establish a representative running pace for the subsequent durability assessment.

In Phase 2, participants will complete prolonged trail-running sessions using the two advanced-foam footwear configurations. Each footwear condition will be assessed during a separate visit. The sessions will consist of repeated running on a 15-km trail course comprising five 3-km loops and approximately 375 m of elevation gain. Running intensity will be based on the pace obtained during the Phase 1 time trial, according to the final study protocol.

Running economy will be assessed repeatedly during the prolonged exercise sessions using portable metabolic measurements. Changes in physiological efficiency and fatigue will be evaluated across the running session. GPS-based measurements will also be collected to monitor pacing and changes in running performance.

The main physiological outcome is running economy, assessed through oxygen consumption and energy cost relative to running speed. Additional physiological, biomechanical, and perceptual outcomes include heart rate, step frequency, step length, ground contact time, rating of perceived exertion, perceived comfort, perceived performance, and pacing-related measures.

The study is designed to determine whether footwear-related differences in running economy identified under controlled laboratory conditions are maintained during real-world trail running. It will also investigate whether advanced-foam footwear configurations influence the deterioration of running economy and fatigue during prolonged trail-running exercise. The findings are intended to contribute to the scientific understanding of interactions between trail-running footwear, biomechanics, physiological responses, and endurance performance.

Tipo de estudio

Intervencionista

Inscripción (Estimado)

30

Fase

  • No aplica

Contactos y Ubicaciones

Esta sección proporciona los datos de contacto de quienes realizan el estudio e información sobre dónde se lleva a cabo este estudio.

Estudio Contacto

Criterios de participación

Los investigadores buscan personas que se ajusten a una determinada descripción, denominada criterio de elegibilidad. Algunos ejemplos de estos criterios son el estado de salud general de una persona o tratamientos previos.

Criterio de elegibilidad

Edades elegibles para estudiar

18 años y mayores (Adulto, Adulto Mayor)

Acepta Voluntarios Saludables

Sí

Géneros elegibles para el estudio

Todos

Descripción

Inclusion Criteria:

  • Competitive trail runners.
  • Experience in technical trail running.
  • Willingness to provide written informed consent.

Exclusion Criteria:

  • Musculoskeletal injury in the previous 6 months.

Plan de estudios

Esta sección proporciona detalles del plan de estudio, incluido cómo está diseñado el estudio y qué mide el estudio.

¿Cómo está diseñado el estudio?

Detalles de diseño

  • Propósito principal: Tratamiento
  • Asignación: Aleatorizado
  • Modelo Intervencionista: Asignación cruzada
  • Enmascaramiento: Único

Armas e Intervenciones

Grupo de participantes/brazo
Intervención / Tratamiento
Experimental: High-Stack Advanced-Foam Footwear

Participants will perform the experimental running trials wearing a high-stack advanced-foam trail-running shoe (approximately 38.5 mm stack height, 6 mm drop, and 220 g). This footwear condition will be used to assess running economy, physiological and biomechanical responses, comfort, perceived performance, and fatigue-related changes during laboratory and field-based trail running.

Three trail running shoes with different characteristics will be compared in terms of their physiological and biomechanical effects.

Experimental: Medium-Stack Advanced-Foam Footwear

Participants will perform the experimental running trials wearing a medium-stack advanced-foam trail-running shoe (approximately 28.5 mm stack height, 6 mm drop, and 180 g). This footwear condition will be used to assess running economy, physiological and biomechanical responses, comfort, perceived performance, and fatigue-related changes during laboratory and field-based trail running.

Three trail running shoes with different characteristics will be compared in terms of their physiological and biomechanical effects.

Comparador activo: Conventional-Foam Footwear

Participants will perform the experimental running trials wearing a conventional-foam trail-running shoe (approximately 31.5 mm stack height, 6 mm drop, and 300 g). This footwear condition will serve as the conventional-footwear comparison for assessing running economy, physiological and biomechanical responses, comfort, perceived performance, and fatigue-related changes during laboratory and field-based trail running.

Three trail running shoes with different characteristics will be compared in terms of their physiological and biomechanical effects.

¿Qué mide el estudio?

Medidas de resultado primarias

Medida de resultado
Medida Descripción
Periodo de tiempo
Running economy
Periodo de tiempo: During each 5-minute running trial for each footwear model in Phase 1 (indoor laboratory conditions) and Phase 2 (outdoor trail-running conditions).

Running economy will be assessed through oxygen consumption (V̇O₂) and energy cost expressed in W·kg-¹ during running in the different footwear conditions. Measurements will be obtained using breath-by-breath gas analysis during controlled laboratory and field-based trail-running trials.

During each 5-minute running trial for each footwear model in Phase 1 (indoor laboratory conditions) and Phase 2 (outdoor trail-running conditions).

Medidas de resultado secundarias

Medida de resultado
Medida Descripción
Periodo de tiempo
Heart Rate
Periodo de tiempo: During each 5-minute running trial for each footwear model in Phase 1 (indoor laboratory conditions) and Phase 2 (outdoor trail-running conditions).

Continuous heart rate will be recorded during the running trials to characterize the physiological response to each footwear condition.

During each 5-minute running trial for each footwear model in Phase 1 (indoor laboratory conditions) and Phase 2 (outdoor trail-running conditions).
Spatiotemporal Gait Parameters
Periodo de tiempo: During each 5-minute running trial for each footwear model in Phase 1 (indoor laboratory conditions) and Phase 2 (outdoor trail-running conditions).

Biomechanical responses will be assessed through step frequency (steps/min), step length (m), and ground contact time (ms) during running in the different footwear conditions.

During each 5-minute running trial for each footwear model in Phase 1 (indoor laboratory conditions) and Phase 2 (outdoor trail-running conditions).
Comfort, Perceived Performance, and Rate of Perceived Exertion
Periodo de tiempo: After each 5-minute running trial for each footwear model in Phase 1 (indoor laboratory conditions) and Phase 2 (outdoor trail-running conditions).

Participants' subjective perceptions of footwear comfort, perceived performance, and rate of perceived exertion will be assessed during the experimental running conditions.

After each 5-minute running trial for each footwear model in Phase 1 (indoor laboratory conditions) and Phase 2 (outdoor trail-running conditions).

Colaboradores e Investigadores

Aquí es donde encontrará personas y organizaciones involucradas en este estudio.

Publicaciones y enlaces útiles

La persona responsable de ingresar información sobre el estudio proporciona voluntariamente estas publicaciones. Estos pueden ser sobre cualquier cosa relacionada con el estudio.

Fechas de registro del estudio

Estas fechas rastrean el progreso del registro del estudio y los envíos de resultados resumidos a ClinicalTrials.gov. Los registros del estudio y los resultados informados son revisados ​​por la Biblioteca Nacional de Medicina (NLM) para asegurarse de que cumplan con los estándares de control de calidad específicos antes de publicarlos en el sitio web público.

Fechas importantes del estudio

Inicio del estudio (Estimado)

1 de noviembre de 2026

Finalización primaria (Estimado)

1 de marzo de 2028

Finalización del estudio (Estimado)

1 de marzo de 2028

Fechas de registro del estudio

Enviado por primera vez

22 de septiembre de 2026

Primero enviado que cumplió con los criterios de control de calidad

28 de septiembre de 2026

Publicado por primera vez (Actual)

2 de octubre de 2026

Actualizaciones de registros de estudio

Última actualización publicada (Actual)

2 de octubre de 2026

Última actualización enviada que cumplió con los criterios de control de calidad

28 de septiembre de 2026

Última verificación

1 de septiembre de 2026

Más información

Términos relacionados con este estudio

Otros números de identificación del estudio

  • CEIS-2026-174642
  • PID2025-170911NB-I00 (Otro número de subvención/financiamiento: Agencia Estatal de Investigación. Ministerio de Ciencia, Innovación y Universidades)

Plan de datos de participantes individuales (IPD)

¿Planea compartir datos de participantes individuales (IPD)?

INDECISO

Descripción del plan IPD

The investigators have not yet decided whether individual participant data (IPD) will be shared. A decision regarding IPD sharing will be made after completion of the study, taking into consideration ethical, legal, privacy, and data protection requirements.

Información sobre medicamentos y dispositivos, documentos del estudio

Estudia un producto farmacéutico regulado por la FDA de EE. UU.

No

Estudia un producto de dispositivo regulado por la FDA de EE. UU.

No

Esta información se obtuvo directamente del sitio web clinicaltrials.gov sin cambios. Si tiene alguna solicitud para cambiar, eliminar o actualizar los detalles de su estudio, comuníquese con register@clinicaltrials.gov. Tan pronto como se implemente un cambio en clinicaltrials.gov, también se actualizará automáticamente en nuestro sitio web. .

Suscribir